SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/688FAA3181082F71A0A819EE6EAE2753E467462D4CF26A2CBE5321339E5FE267BF8B5415054EFDA84C19B9417FE6AEBA>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/688FAA3181082F71A0A819EE6EAE2753E467462D4CF26A2CBE5321339E5FE267BF8B5415054EFDA84C19B9417FE6AEBA
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/688FAA3181082F71A0A819EE6EAE2753E467462D4CF26A2CBE5321339E5FE267BF8B5415054EFDA84C19B9417FE6AEBA
http://www.w3.org/2000/01/rdf-schema#comment
"Our data suggest that the combined treatment with chemotherapy and GST(GSTM1 GSTM4 and GSTT1 ) inhibitors such as EA might be an interesting option for patients with chemoresistant Hodgkin's lymphoma"
xsd:string
http://purl.uniprot.org/uniprot/#_D7A107844F50C272C03B9CBFB5069A6585EE1B29E4EDBDCA4C0BD118193219FF3C16ADE7E8470B4040A48F708AC43235
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/688FAA3181082F71A0A819EE6EAE2753E467462D4CF26A2CBE5321339E5FE267BF8B5415054EFDA84C19B9417FE6AEBA
http://purl.uniprot.org/uniprot/A0A0G2JRQ5
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/688FAA3181082F71A0A819EE6EAE2753E467462D4CF26A2CBE5321339E5FE267BF8B5415054EFDA84C19B9417FE6AEBA
http://purl.uniprot.org/uniprot/#_A0A0G2JRQ5-mappedCitation-27466493
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/688FAA3181082F71A0A819EE6EAE2753E467462D4CF26A2CBE5321339E5FE267BF8B5415054EFDA84C19B9417FE6AEBA